>

>

Oncology Competitive Landscape, April 2020: Searching for White Space

Service Areas

Commercial Strategy

Therapeutic Areas

Oncology

Published Date

Industry Topics

Oncology, Competitive Landscape, Clinical Development

Our Perspective

It is always a challenge to prioritize indications with an oncology asset. Most drug candidates have multiple applications across a wide set of malignancies and a complex set of competition with an overwhelming competitive landscape with thousands of trials.

To assist in this process, First Principles created a framework to analyze 21 solid tumors and hematologic malignancies, which can also easily integrate any company's technology into its rubric to determine the best white spaces for development.

This report is valuable in its own right, providing insight on the slivers of white space in the oncology therapeutic area, and also as a missing link for any firm that wants to analyze the oncology market, in order to prioritize its clinical research rigorously.

Visit the link below to download an 8-page summary of the paper with abstract, methodology, table of contents. The price is $2,500 to purchase the full report.

Link: rebrand.ly/Onc-CI

Download White Paper

You'll receive communications from First Principles Advisory periodically

More Reading

Case Study: Immuno-oncology competitive intelligence

Case Study: Landscape assessment, development opportunities, and forecasting for novel prostate cancer molecule

Case Study: Portfolio planning and management

Download White Paper

You'll receive communications from First Principles Advisory periodically

Featured Consultants

Mitchell Kossar

Richard Koo

Andy Ghosal

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net